Filter By Topic:
View All +
News
03.27.24
New Study Examines the Risk of Relapse in Those Discontinuing MS TherapyNews
03.27.24
Deadline Approaching for Grant Submissions to American Epilepsy Society for FundingNews
03.26.24
The First Long-Acting C5 Complement Inhibitor Treatment for Adults with AQP4+ NMOSD ApprovedNews
03.25.24
Duvyzat Approved by FDA As Treatment for Duchenne Muscular DystrophyNews
03.19.24
FDA Approves First Gene Therapy for Children with Metachromatic LeukodystrophyNews
03.18.24
Agamree Now Commercially Available in the United States as Treatment for Duchenne Muscular DystrophyNews
03.15.24
New Partnership Between myTomorrows and the ALS Association Aims to Expand Clinical Trial ParticipationNews
03.15.24
Dual Antiplatelet Therapy Superior to Aspirin Alone in Reducing Early Neurologic Deterioration in People with Mild-to-Moderate Ischemic StrokeNews
03.13.24
Novel Tau-Targeting Medication for Alzheimer Disease Associated with Sustained Cognitive BenefitNews
03.13.24
American Headache Society Issues New Migraine Prevention GuidanceNews
03.08.24
Donanemab Decision Delayed by FDANews
03.08.24
Wearable Device for Migraine Treatment Receives Commercial Coverage in the United StatesNews
03.06.24
Promising Outcomes in Multiple Endpoints Reported with Delpacibart Etedesiran Treatment for Myotonic Dystrophy Type 1News
03.05.24
New MoCA Smartphone App Enables Users to Self-Assess Their Cognitive FunctionNews
03.04.24
Uplizna Safe and Effective for Adults Aged ≥50 Years with AQP4+ NMOSDNews
03.04.24
Muscular Dystrophy Association Applauds Landmark Proposal on Accessible Air TravelNews
03.01.24
Investigational Small Molecule Therapy for Progressive MS Associated with Reduced Serum NfL Levels Compared with PlaceboNews
03.01.24
Study Assesses Biological Age Acceleration in People with Multiple SclerosisNews
02.29.24
OTC Antihistamine Clemastine May Accelerate Disability in Those with Progressive MSNews
02.29.24
Barancik Prize Awarded to Sergio E. Baranzini, PhD at ACTRIMS 2024Wilmar Jolink, MD, PhD, and Doeschka Ferro, MD, PhD
Katrina Roberto, MD, and Mary Jane Lim-Fat, MD, MSc